-
Article
Open AccessSubstantia nigral dopamine transporter uptake in dementia with Lewy bodies
Nigrostriatal dopaminergic degeneration is a pathological hallmark of dementia with Lewy bodies (DLB). To identify the subregional dopamine transporter (DAT) uptake patterns that improve the diagnostic accurac...
-
Article
Open AccessEffects of Alzheimer’s genetic risk scores and CSF biomarkers in de novo Parkinson’s Disease
Coexisting Alzheimer’s disease (AD) pathology is common in Parkinson’s disease (PD). However, the implications of genetic risk scores (GRS) for AD have not been elucidated in PD. In 413 de novo PD and 195 heal...
-
Article
Open AccessImplication of metabolic and dopamine transporter PET in dementia with Lewy bodies
To evaluate the implication of 18F-fluorodeoxyglucose (FDG)- and dopamine transporter (DAT)-positron emission tomography (PET) in the diagnosis and clinical symptoms of dementia with Lewy bodies (DLB), 55 DLB pat...